Tirzepatide helps people with obesity reduce weight, lower blood pressure, and improve cholesterol levels

Once-weekly tirzepatide led to substantial body weight reductions in people with obesity, including those with type 2 diabetes.

• Modest decreases in body weight are linked to significant improvements in various health-related outcomes.
• The SURMOUNT clinical trial program evaluated the effects of tirzepatide on weight loss.
• Participants experienced weight reductions regardless of their diabetes status.

Simplified